Assertio Holdings Faces Multiple Legal Challenges

Investigations and class action lawsuits target Assertio Holdings, Inc. over alleged securities law violations and misleading statements.

Assertio Holdings, Inc. is under investigation by the Portnoy Law Firm for potential losses to investors following FDA approval of a competitor's generic drug.
Kessler Topaz Meltzer & Check, LLP announces a securities class action lawsuit against Assertio, citing fraudulent misrepresentations and omissions.
Bronstein, Gewirtz & Grossman, LLC files a class action lawsuit on behalf of Assertio investors, alleging violations of federal securities laws between March 9, 2023, and November 8, 2023.
Assertio's stock price plummeted following the FDA's approval of a generic competitor and disappointing financial results.
The company's acquisition of Spectrum Pharmaceuticals Inc. in July 2023 is now under scrutiny for not meeting initial expectations.